Michael Fischereder

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany.

Epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany.

Journal: Research and practice in thrombosis and haemostasis
Published: April 12, 2026

Acute Kidney Injury in Immune-Mediated Thrombotic Thrombocytopenic Purpura - Solving the Puzzle?

Acute Kidney Injury in Immune-Mediated Thrombotic Thrombocytopenic Purpura - Solving the Puzzle?

Journal: Kidney international reports
Published: October 29, 2025

Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging.

Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging.

Journal: Seminars in nuclear medicine
Published: September 10, 2025

Correction to: Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Correction to: Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Journal: Kidney360
Published: August 26, 2025

An Offline SPE-LC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Cyclosporine A, Kynurenine, Tryptophan, and Creatinine Using Volumetric Absorptive Microsampling Device Mitra.

An Offline SPE-LC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Cyclosporine A, Kynurenine, Tryptophan, and Creatinine Using Volumetric Absorptive Microsampling Device Mitra.

Journal: Therapeutic drug monitoring
Published: November 02, 2024

Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia.

Journal: Kidney360
Published: April 30, 2024

Sapovirus: an emerging pathogen in kidney transplant recipients?

Sapovirus: an emerging pathogen in kidney transplant recipients?

Journal: Infection
Published: February 06, 2024

Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex.

Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex.

Journal: Orphanet journal of rare diseases
Published: November 21, 2023

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.

Journal: Frontiers in medicine
Published: November 09, 2023

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.

Journal: BMJ open
Published: November 11, 2022

Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Journal: Frontiers in immunology
Published: November 04, 2022

Corrigendum: Disqualification of donor and recipient candidates from the living kidney donation program: Experience of a single-center in Germany.

Corrigendum: Disqualification of donor and recipient candidates from the living kidney donation program: Experience of a single-center in Germany.

Journal: Frontiers in medicine
Published: July 27, 2022
Showing 1-12 of 87

Last Updated: 09/26/2026